InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Moderna

MRNA Clue Score25
United States Fiscal year ends December CIK 0001682852 Results filed 31 Jul 2026
Add to watchlist

What the insiders did Scheduled selling only

Individual transactions

20
Insider
Date
Role
Action
Shares
Price
Amount
Stephen Hoge
15 Oct 2026
President
Sold after exercise
39,145
$220.72
$8.64M
Stephen Hoge
14 Oct 2026
President
Sold after exercise
450
$214.15
$96.37K
Stephen Hoge
14 Oct 2026
President
Sold after exercise
38,774
$213.47
$8.28M
Stephen Hoge
15 Sep 2026
President
Sold after exercise
40,281
$146.07
$5.88M
Stephen Hoge
14 Sep 2026
President
Sold after exercise
40,294
$144.13
$5.81M
James M Mock
10 Sep 2026
Chief Financial Officer
Sold after exercise
15,000
$134.49
$2.02M
James M Mock
10 Sep 2026
Chief Financial Officer
Sold after exercise
19,836
$134.49
$2.67M
Shannon Thyme Klinger
1 Sep 2026
Chief Legal Officer
Sold after exercise
3,471
$139.95
$485.77K
Stephane Bancel
5 Aug 2026
Chief Executive Officer
Sold after exercise
187,044
$58.79
$11.00M
Stephane Bancel
5 Aug 2026
Chief Executive Officer
Sold after exercise
39,891
$58.12
$2.32M
Stephane Bancel
5 Aug 2026
Chief Executive Officer
Sold after exercise
124,838
$56.96
$7.11M
Stephane Bancel
5 Aug 2026
Chief Executive Officer
Sold after exercise
147,473
$56.21
$8.29M
Stephen Hoge
15 Jul 2026
President
Sold after exercise
53,336
$67.60
$3.61M
Stephen Hoge
15 Jun 2026
President
Sold after exercise
53,336
$51.37
$2.74M
Shannon Thyme Klinger
4 Jun 2026
Chief Legal Officer
Sold after exercise
3,471
$50.00
$173.55K
Noubar Afeyan
21 May 2026
Director
Sold after exercise indirect
9,263
$46.84
$433.88K
Stephen Hoge
15 May 2026
President
Sold after exercise
53,336
$48.40
$2.58M
Shannon Thyme Klinger
2 Mar 2026
Chief Legal Officer
Sold after exercise
13,885
$52.29
$726.05K
Stephen Hoge
23 Feb 2026
President
Sold after exercise
160,009
$48.84
$7.81M
Noubar Afeyan
11 Dec 2025
Director
Sold after exercise indirect
23,853
$29.49
$703.31K
Show all 24 transactions →

What was left out

Form 4 filings counted 64
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 20
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 2,649,813
History held since 13 Dec 2018